Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiten R H Patel

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Expert Review of Anticancer Therapy|August 23, 2014
Biomarkers and personalized risk stratification for patients with clinically localized prostate cancerPedro Costa-Pinheiro, Hiten R H Patel, Rui Henrique, et al.
Expert Review of Anticancer Therapy|December 8, 2007
Molecular therapeutic targets for bladder cancerEvangelos Zacharakis, Mahmoud Monem, Jean V Joseph, et al.
BJU International|August 2, 2006
Three-dimensional visualization in laparoscopic surgeryPeter Pietrzak, Manit Arya, Jean V Joseph, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 19, 2007
Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migrationManit Arya, Hashim Ahmed, Nitika Silhi, et al.
BMC Urology|September 9, 2024
Comparing open and robot-assisted partial nephrectomy - a single institution reportMarius Roaldsen, Vetle Lohne, Thor Allan Stenberg, et al.
Expert Review of Anticancer Therapy|October 1, 2014
Robotic and minimal access surgery: technology and surgical outcomes of radical prostatectomy for prostate cancerStig Müller, Leif Erik Grønning, Frode S Nilsen, et al.
BJU International|December 21, 2011
Predicting erectile function outcome in men after radical prostatectomy for prostate cancerShaun Kilminster, Stig Müller, Mani Menon, et al.
Integrative Cancer Therapies|February 23, 2008
Significance of alterations in plasma lipid profile levels in breast cancerFranky Dhaval Shah, Shilin Nandubhai Shukla, Pankaj Manubhai Shah, et al.
Expert Review of Anticancer Therapy|April 18, 2019
Chronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC): can this lead to the adverse effect of hypogonadism?Mehran Afshar, Hiten R H Patel, Ankit Jain, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 19, 2007
Utility of urinary biomarkers in oral cancerJayendra B Patel, Shilin N Shukla, Hiten R H Patel, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Expert Review of Anticancer Therapy|August 23, 2014
Biomarkers and personalized risk stratification for patients with clinically localized prostate cancerPedro Costa-Pinheiro, Hiten R H Patel, Rui Henrique, et al.
Expert Review of Anticancer Therapy|December 8, 2007
Molecular therapeutic targets for bladder cancerEvangelos Zacharakis, Mahmoud Monem, Jean V Joseph, et al.
BJU International|August 2, 2006
Three-dimensional visualization in laparoscopic surgeryPeter Pietrzak, Manit Arya, Jean V Joseph, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 19, 2007
Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migrationManit Arya, Hashim Ahmed, Nitika Silhi, et al.
BMC Urology|September 9, 2024
Comparing open and robot-assisted partial nephrectomy - a single institution reportMarius Roaldsen, Vetle Lohne, Thor Allan Stenberg, et al.
Expert Review of Anticancer Therapy|October 1, 2014
Robotic and minimal access surgery: technology and surgical outcomes of radical prostatectomy for prostate cancerStig Müller, Leif Erik Grønning, Frode S Nilsen, et al.
BJU International|December 21, 2011
Predicting erectile function outcome in men after radical prostatectomy for prostate cancerShaun Kilminster, Stig Müller, Mani Menon, et al.
Integrative Cancer Therapies|February 23, 2008
Significance of alterations in plasma lipid profile levels in breast cancerFranky Dhaval Shah, Shilin Nandubhai Shukla, Pankaj Manubhai Shah, et al.
Expert Review of Anticancer Therapy|April 18, 2019
Chronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC): can this lead to the adverse effect of hypogonadism?Mehran Afshar, Hiten R H Patel, Ankit Jain, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 19, 2007
Utility of urinary biomarkers in oral cancerJayendra B Patel, Shilin N Shukla, Hiten R H Patel, et al.
Pageof 3